Correction
for
Travis et al., Gut 55 (Supplement 1) i16-i35.
Gut 2006;55:437
Copyright © 2006 BMJ Publishing Group Ltd & British Society of Gastroenterology
Digest
Robin Spiller,
Alastair Watson, Editor and Deputy Editor
| The first 150 words of the full text of this article appear below. |
CROSS LINKING OF GLIADIN BY TISSUE TRANSGLUTAMINASE IS A CRITICAL PART OF THE PATHOGENESIS OF COELIAC DISASE
It is know that short peptides from
-gliaden stimulate T cells in coeliac disease. The binding of these peptides to human leukocyte antigens (DQ2 and DQ8) is greatly enhanced when the peptides are deamidated by tissue transglutaminase. It has been hypothesised that the deamidation of a few specific gliadin peptides is responsible for the chronic inflammation of coeliac disease. However, this hypothesis has not been tested directly. Data are presented that tissue transglutaminase can deamidate a wide range of gliadin peptides. Furthermore, deamidation causes the binding and long term immobilisation of gliadin peptides to collagen, which contributes the chronicity of inflammation. This binding is also associated with increased titres of anticollagen antibodies, which may explain the high incidence of autoimmune disease in coeliac patients.
See p 478
| |
Tissue transglutaminase expression in the wall of the oesophagus.
|
|
HOW JEJUNAL INFLAMMATION INDUCES ANOREXIA: ROLE OF CCK AND 5-HT
Many inflammatory illnesses are associated with anorexia but the mechanisms involved are uncertain. The . . . [Full text of this article]
Relevant Articles
-
Cross linking to tissue transglutaminase and collagen favours gliadin toxicity in coeliac disease
- W Dieterich, B Esslinger, D Trapp, E Hahn, T Huff, W Seilmeier, H Wieser, and D Schuppan
Gut 2006 55: 478-484.
[Abstract]
[Full Text]
[PDF]
-
Vanilloids in pancreatic cancer: potential for chemotherapy and pain management
- M Hartel, F F di Mola, F Selvaggi, G Mascetta, M N Wente, K Felix, N A Giese, U Hinz, P Di Sebastiano, M W Büchler, and H Friess
Gut 2006 55: 519-528.
[Abstract]
[Full Text]
[PDF]
-
Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial
- T N Brooklyn, M G S Dunnill, A Shetty, J J Bowden, J D L Williams, C E M Griffiths, A Forbes, R Greenwood, and C S Probert
Gut 2006 55: 505-509.
[Abstract]
[Full Text]
[PDF]
-
In vivo imaging of cerebral "peripheral benzodiazepine binding sites" in patients with hepatic encephalopathy
- A Cagnin, S D Taylor-Robinson, D M Forton, and R B Banati
Gut 2006 55: 547-553.
[Abstract]
[Full Text]
[PDF]
-
Four year follow up of fatigue in a geographically defined primary biliary cirrhosis patient cohort
- D E J Jones, N Bhala, J Burt, J Goldblatt, M Prince, and J L Newton
Gut 2006 55: 536-541.
[Abstract]
[Full Text]
[PDF]
-
Immune control of food intake: enteroendocrine cells are regulated by CD4+ T lymphocytes during small intestinal inflammation
- J R McDermott, F C Leslie, M DAmato, D G Thompson, R K Grencis, and J T McLaughlin
Gut 2006 55: 492-497.
[Abstract]
[Full Text]
[PDF]
Terms and conditions relating to subscriptions purchased online ¦ Website terms and conditions ¦ Privacy policy
Copyright © 2006 BMJ Publishing Group Ltd & British Society of Gastroenterology